Novo Nordisk Pharma d.o.o. Beograd is the Serbian affiliate of Novo Nordisk, the global pharmaceutical company specializing in diabetes care, obesity treatment and biopharmaceutical therapies. The company's business segments include sales, marketing, medical support and distribution of prescription medicines, primarily insulin therapies, GLP 1 products and chronic disease treatments. It cooperates with healthcare institutions, pharmacies and medical professionals across Serbia. Key assets include a portfolio of internationally recognized pharmaceutical products and medical education programs. Strategically, Novo Nordisk Pharma d.o.o. focuses on improving access to innovative treatments and supporting long term chronic disease management in Serbia.
Headquarters
Milutina Milankovica 9 B
Belgrade; Belgrade;
Contact Details: Purchase the Novo Nordisk Pharma D.O.O. Beograd report to view the information.
Website: http://www.novonordisk.rs
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service